Sensipar Disease Interactions
There are 3 disease interactions with Sensipar (cinacalcet).
Cinacalcet (applies to Sensipar) hypocalcemia
Moderate Potential Hazard, Moderate plausibility.
Cinacalcet lowers serum calcium, and therefore patients should be carefully monitored for the occurrence of hypocalcemia. Potential manifestations of hypocalcemia include paresthesias, myalgias, cramping, tetany, and convulsions. Cinacalcet treatment should not be initiated if serum calcium is less than the lower limit of the normal range (8.4 mg/dL). Monitor serum calcium 1 week after treatment initiation or dose adjustment, and once every month once the maintenance dose has been established.
Cinacalcet (applies to Sensipar) hypotension
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Heart Disease
Postmarketing safety surveillance studies have reported cases of hypotension, worsening heart failure and/or arrhythmias in patients with impaired cardiac function receiving cinacalcet. A causal relationship could not been excluded and this may be mediated by reductions in serum calcium. Cinacalcet should be used with caution in patients with hypotension or preexisting impaired cardiac function.
Cinacalcet (applies to Sensipar) seizures
Moderate Potential Hazard, Moderate plausibility.
Cinacalcet may lower seizure threshold in patients with a history of seizures. Serum calcium levels should be closely monitored in patients receiving cinacalcet, particularly in patients with history of seizure disorders.
Switch to professional interaction data
Sensipar drug interactions
There are 158 drug interactions with Sensipar (cinacalcet).
Sensipar alcohol/food interactions
There are 2 alcohol/food interactions with Sensipar (cinacalcet).
More about Sensipar (cinacalcet)
- Sensipar consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (9)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: calcimimetics
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Prolia
Prolia (denosumab) is an injection that is administered subcutaneously (under the skin) once every ...
Decadron
Decadron is used for addison's disease, adrenal insufficiency, adrenocortical insufficiency ...
Taltz
Taltz (ixekizumab) is used to treat plaque psoriasis, psoriatic arthritis, and ankylosing ...
Reclast
Reclast (zoledronic acid) is used to treat osteoporosis in women after menopause and also to treat ...
Zometa
Zometa is used to treat high blood levels of calcium caused by cancer and multiple myeloma. Learn ...
Deltasone
Deltasone is used for acute lymphocytic leukemia, adrenocortical insufficiency, allergic reactions ...
Zemplar
Zemplar (paricalcitol) is used to treat secondary hyperparathyroidism in people with chronic kidney ...
Doxercalciferol
Doxercalciferol systemic is used for secondary hyperparathyroidism
Paricalcitol
Paricalcitol systemic is used for secondary hyperparathyroidism
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.